A phase 2 study evaluated the efficacy and safety of adding pembrolizumab to trimodal therapy as a bladder-sparing approach for muscle-invasive bladder cancer (MIBC).

Revised trial procedures add intensified hematologic and cardiac monitoring to mitigate toxicities consistent with dual ...

UFC 327 had all the ingredients needed to make an all-time great fight card.

Saturday's Oaklawn Handicap in Arkansas shapes up as the race of the year, with Sovereignty, Journalism and White Abarrio set ...

The results suggest the drug boasts similar safety and efficacy in non-small cell lung cancer compared with the field’s ...

Clinically meaningful improvements in xerostomia symptoms measured by PRO Xerostomia Questionnaire (XQ) maintained out to 3 years post treatment with AAV-hAQP1 for both bilateral and unilateral ...

Trastuzumab pamirtecan, a HER2-targeted antibody-drug conjugate, achieved ‘exceptional’ antitumor responses in patients with recurrent endometrial cancer, especially those with HER2 IHC 3+ tumors.

Paclitaxel remains first-line for cutaneous angiosarcoma, but absence of validated second-line therapy creates a major unmet ...

Also from SGO: p53 reactivator active in advanced gynecologic cancers, "perfect" score in ...

Shares iBoxx High Yield Bond ETF (HYG) — 19 years of uninterrupted monthly payments on diversified junk bond portfolio. HYG’s ...

The Houston Rockets face the Los Angeles Lakers in Game 1 of the first round of the NBA Playoffs, and Kevin Durant's ...

Talisker Resources Ltd. ('Talisker” or the 'Company”) (TSX: TSK, OTCQB: TSKFF) is pleased to report the development on the ...